Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Advanced Pancreatic Cancer With Opioid Growth Factor (OGF): Phase II

NCT00109941 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.

NCT NCT00109941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Advanced Pancreatic Cancer With Opioid Growth Factor (OGF): Phase II
Lead sponsor
Milton S. Hershey Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
April 30, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer